Landmark Advancement in Flow Cytometry Technology With Potential To Transform Immunology and Genomics Research
Technology breakthrough has potential to transform wide range of disciplines from immunology and genomics research to cell-based therapeutics. BD (Becton, Dickinson and Company) (NYSE: BDX),…